Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00994162 · ClinicalTrials.gov registry record · NA
Evaluation of the Use of EZCare/V1STA in the Management of Acute and Chronic Wounds
A NA study, sponsored by Smith & Nephew.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
NCT00994162: Completed NA study, sponsored by Smith & Nephew.
NCT00994162 is a NA study that has completed, run by Smith & Nephew. The registered enrollment target is 153 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00994162, a NA study, has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
Study Summary
The aim of this evaluation is to assess the performance of the EZCare/V1STA products, in many different clinical environments, in order to gain a greater insight into the effects of this negative pressure wound therapy (NPWT) in a variety of wound types.
Primary Outcome
Evaluation was conducted to determine the extent of wound progression by the use of the NPWT EZCare/V1STA devices. Analysis of the amount of granulation tissue formation, successful management of exudate, and wound progression by reduction in area, volume, and depth were measured to assess improvement in wound healing. The wound was measured to assess wound area at Baseline.
Interventions
- DEVICE EZCare/V1STA Negative Pressure Wound Therapy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-07 |
| Phase | NA |
What the finished NCT00994162 record still lists
NCT00994162 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which EZCare/V1STA Negative Pressure Wound Therapy System is the first listed.
NCT00994162 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00994162 about?
NCT00994162 is a clinical study titled "Evaluation of the Use of EZCare/V1STA in the Management of Acute and Chronic Wounds". The aim of this evaluation is to assess the performance of the EZCare/V1STA products, in many different clinical environments, in order to gain a greater insight into the effects of this negative pressure wound therapy (NPWT) in a variety of wound types.
What is the current status of trial NCT00994162?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2008-04. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00994162?
The interventions under investigation include: EZCare/V1STA Negative Pressure Wound Therapy System (DEVICE).
Who is sponsoring clinical trial NCT00994162?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00994162's enrollment target sits among peer trials
153 656th of 2000 higher than 1,343 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia